Login to Your Account



Genentech, OSI Begin Phase II With Tarceva For Brain Cancer

By Randall Osborne


Monday, August 11, 2003
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription